Table 1 Demographic and clinical characteristics of patients at admission
From: Clinical characteristics of cerebral venous sinus thrombosis patients with new-onset of headache
Headache groups n = 52 | Non-headache groups n = 17 | X2/Z-value | P-value | |
|---|---|---|---|---|
Gender (male/female) | 23/29 | 12/5 | 4.947 | 0.025 |
Age (years) | 37 (27, 45) | 50 (38, 67) | -2.862 | 0.004 |
Subgroups | ||||
Acute stage | 28 (53.84%) | 11 (64.70%) | 1.423 | 0.0491 |
Subacute stage | 15 (28.85%) | 5 (29.41%) | ||
Chronic stage | 9 (17.31%) | 1 (9.09%) | ||
ATCVS | 3 (1, 4) | 3 (1, 3) | -0.732 | 0.670 |
SBP (mmHg) | 121 (112, 131) | 129 (120, 141) | -1.928 | 0.054 |
DBP (mmHg) | 74 (67, 80) | 78.5 (69, 89.75) | -1.132 | 0.258 |
WBC (× 109/L) | 7.33 (5.78, 8.92) | 8.05 (6.49, 11.06) | -1.436 | 0.151 |
L (× 109/L) | 1.7 (1.09, 2.08) | 1.39 (1.05, 2.24) | -0.555 | 0.579 |
LR (%) | 0.25(0.172,0.327) | 0.18 (0.14, 0.236) | -2.076 | 0.038 |
MCV (ng/L) | 88.10 (84, 91) | 90.4 (88.65, 92.40) | -2.112 | 0.035 |
USG | 1.014 (1.010, 1.020) | 1.013 (1.010, 1.015) | -0.993 | 0.479 |
HBs-Ab (ug/ml) | 24.03(24.03,154.54) | 28.07 (5.97,154.56) | -0.271 | 0.787 |
BUN (mg/L) | 3.5 (2.80, 4.15) | 4.75 (3.90, 6.00) | -3.052 | 0.002 |
ICP (mm H2O) | 234 (200, 290) | 200 (171.25, 234) | -2.237 | 0.025 |
Protein (CSF) (g/L) | 0.55 (0.284, 0.605) | 0.605 (0.605, 0.995) | -3.103 | 0.002 |
ADA (CSF) (U/L) | 0.4 (0.20, 0.73) | 0.73 (0.40, 0.73) | -1.638 | 0.101 |
LDH (CSF) (U/L) | 28 (22, 54) | 50 (34, 54) | -2.004 | 0.045 |
CL (CSF) (mmonl/L) | 121.50 (120.70, 125.30) | 120.70 (120.70, 123.67) | -1.384 | 0.166 |
NHISS (at discharge) | 0.00 (0, 1) | 0.5 (0, 1.75) | -1.798 | 0.072 |
Treatment method | ||||
Low molecular heparin | 50 (96.15%) | 17 (100%) | 0.673 | 0.412 |
Intravascular treatment | 2 (3.84%) | 0 (0) | ||
Prognosis | ||||
Improved | 50 (96.15%) | 14 (82.35%) | 9.393 | 0.024 |
Exacerbation/complications | 1 (1.92%) | 3 (17.65%) | ||
Death | 1 (1.92%) | 0 (0) | ||